Despas F, Chaouki M, de Barros S, Bonneau B, et al. Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure. Leuk Lymphoma 2024 May 15:1-3. doi: 10.1080/10428194.2024.2353330.
PMID: 38747179